High field magnetic resonance imaging evaluation of superparamagnetic iron oxide nanoparticles in a permanent rat myocardial infarction

Investigative Radiology

Volumn 38, Issue 3, 2003, Pages 141-146

  Chapon, C ^a   Franconi, F ^a   Lemaire, L ^a,d   Marescaux, L ^b   Legras, P ^c   Saint Andre J P ^c   Denizot, B ^a   Le Jeune, J J ^a  

^a UNIVERSITÉ D'ANGERS   (France)

^b LUNAM UNIVERSITÉ   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d INSERM   (France)

Author keywords

Cardiac MRI; High magnetic field; Iron oxide particles; T2 weighted sequence

Indexed keywords

NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DOSE RESPONSE; DRUG HALF LIFE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HIGH FIELD MAGNETIC RESONANCE IMAGING; IMAGE ANALYSIS; IMAGE QUALITY; IMAGE RECONSTRUCTION; MAGNETIC FIELD; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SIGNAL NOISE RATIO; SIGNAL PROCESSING; STATISTICAL ANALYSIS;

EID: 0348150712     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RLI.0000052979.96332.90     Document Type: Article

References (30)

1. Marescaux L, Franconi F, Furber A, et al. Proc. ESMRMB, Sevilla 1999;MAGMA:8(suppl 1); abst. 322.
2. Ruff J, Wiesmann F, Lanz T, et al. Magnetic resonance imaging of coronary arteries and heart valves in a living mouse: techniques and preliminary results. J Magn Reson 2000;146:290-296.
3. Nahrendorf M, Wiesmann F, Hiller KH, et al. In vivo assessment of cardiac remodeling after myocardial infarction in rats by cinemagnetic resonance imaging. J Cardiovasc Magn Reson 2000;2:171-180.
4. Waller C, Hiller KH, Kahler E, et al. Serial magnetic resonance imaging of microvascular remodeling in the infarcted rat heart. Circulation 2001;103:1564-1569.
5. Nahrendorf M, Wiesmann F, Hiller KH, et al. Serial cine-magnetic resonance imaging of left ventricular remodeling after myocardial infarction in rats. J Magn Reson Imaging 2001;14:547-555.
6. Ramani K, Judd RM, Holly TA, et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. Circulation 1998;98:2687-2694.
7. Dendale P, Franken PR, Block P, et al. Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction. Am Heart J 1998;135:875-880.
8. Pereira RS, Prato FS, Wisenberg G, et al. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med 1996;36:684-693.
9. Weinmann HJ, Brasch RC, Press WR, et al. Characteristics of Gadolinium-DTPA complex: a potential NMR contrast agent. Am J Radiol 1984;142:619-624.
10. De Roos A, Doombos J, Van der Wall EE, et al. Imaging of acute myocardial infarction: Value of Gd-DTPA. AJR 1988;150:531-534.
11. Lim TH, Lee JH, Gong G, et al. Significance of magnetic resonance signal enhancement in evaluation of myocardial infarction in cats. Invest Radiol 1995;30:306-314.
12. Okon E, Pouliquen D, Okon P, et al. Biodegradation of magnetite dextran nanoparticles in the rat: a histologic and biophysical study. Laboratory Invest 1994;71:895-903.
13. Rousseau V, Pouliquen D, Darcel F, et al. NMR investigation of experimental chemical induced brain tumors in rats, potential of a superparamagnetic contrast agent (MD3) to improve diagnosis. MAGMA 1998;6:13-21.
14. Chambon C, Clement O, Le Blanche A, et al. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. Magn Reson Med 1993;11:509-519.
15. Canet E, Revel D, Forrat R, et al. Superparamagnetic iron oxide particles and positive enhancement for myocardial perfusion studies asssessed by second T1-weighted MRI. Magn Reson Imaging 1993;11:1139-1145.
16. Bjerner T, Ericsson A, Wikström G, et al. Evaluation of nonperfused myocardial ischemia with MRI and an Intravascular USPIO Contrast agent in an ex vivo pig model. J Magn Reson Imaging 2000;12:866-872.
17. Molday RS, Mc Kenzie D. Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J Immunol Methods 1982;52:353-367.
18. Pouliquen D, Le Jeune JJ, Perdrisot R, et al. Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism. Magn Reson Imaging 1991;9:275-283.
19. Messager T, Franconi F, De Bray JM, et al. Contrast agents relaxivities evolution with magnetic field strength (0.47-7 Teslas). Proc. ESMRMB, Sevilla 1999;MAGMA:8(suppl 1); Abst. 500.
20. Selye H, Bajusz E, Grasso S, et al. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 1960;11:398-407.
21. Fabiani JN, Deloche A, Camilleri JP, et al. Protocole d'étude de l'ischémie aiguë du myocarde chez le rat. Ann Chir Thorac Cardiovasc 1977;16:167-171.
22. Haase A, Frahm J, Matthei D, et al. Flash images. Rapid NMR imaging using low flip angles pulses. J Magn Reson 1986;67:258.
23. Hennig J, Nauerth A, Friedburg H. RARE imaging: A fast imaging method for clinical MR. Magn Reson Med 1986;3:823-833.
24. Pereira RS, Prato FS, Wisenberg G, et al. The use of Gd-DTPA as a marker of myocardial viability in reperfused acute myocardial infarction. Int J Cardiovasc Imaging 2001;17:395-404.
25. Verhnet H, Revel D, Arteaga C, et al. Predictive value of regional left ventricular circumferential shortening in jeopardized myocardium. A two-dimensional SPAMM cine-MRI study in a canine model. Invest Radiol 1999;34:621-628.
26. Panting JR, Taylor AM, Gatehouse PD, et al. First-pass myocardial perfusion Imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection. J Magn Reson Imaging 1999;10:404-410.
27. Amano Y, Herfkens RJ, Shifrin RY, et al. Three-Dimensional cardiac cine magnetic resonance imaging with an ultrasmall Superparamagnetic Iron Oxide Blood Pool agent (NC100150). J Magn Reson Imaging 2000;11:81-86.
28. Pflugfelder PW, Wisenberg G, Prato FS, et al. Serial imaging of canine myocardial infarction by in vivo nuclear magnetic resonance. J Am Coll Cardiol 1986;7:843-849.
29. Dymarkowski S, Ni Y, Miao Y, et al. Value of T2-weighted magnetic resonance imaging early after myocardial infarction in dogs: comparison with bis-gadolinium-mesoporphyrin enhanced T1-weighted magnetic resonance imaging and functional data from cine magnetic resonance imaging. Invest Radiol 2002;2:77-85.
30. Choi SI, Jiang CZ, Lim KH, et al. Application of breath-hold T2-weighted, first-pass perfusion and gadolinium-enhanced T1-weighted MR imaging for assessment of myocardial viability in a pig model. J Magn Reson Imaging 2000;11:476-480.